Drug Shortage Report for ACT BUPROPION XL

Last updated on 2019-10-10 History
Report ID 68572
Drug Identification Number 02439654
Brand name ACT BUPROPION XL
Common or Proper name BUPROPION XL
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-12-01
Estimated end date 2019-10-31
Actual end date 2019-10-09
Shortage status Resolved
Updated date 2019-10-10
Company comments Allocating inventory to support regular demand. Cannot support increased demand for this molecule, as well as now delays in releases from the mfg site.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-10-10 French Compare
v18 2019-10-10 English Compare
v17 2019-10-03 French Compare
v16 2019-10-03 English Compare
v15 2019-10-03 English Compare
v14 2019-09-10 French Compare
v13 2019-09-10 English Compare
v12 2019-09-10 French Compare
v11 2019-09-10 English Compare
v10 2019-08-29 French Compare
v9 2019-08-29 English Compare
v8 2019-08-06 French Compare
v7 2019-08-06 English Compare
v6 2019-06-04 French Compare
v5 2019-06-04 English Compare
v4 2019-04-11 French Compare
v3 2019-04-11 English Compare
v2 2018-12-04 French Compare
v1 2018-12-04 English Compare